论文部分内容阅读
目的探究氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的临床疗效。方法选择本院收治的高血压合并冠心病患者80例为探究对象,随机分为试验组和对照组各40例。试验组进行口服氨氯地平阿托伐他汀钙片治疗,对照组为阿托伐他汀治疗,对比2个组别的临床总有效率及治疗后患者的胆固醇、三酰甘油及高密度脂蛋白。结果治疗后所有患者身体状况均有所改善,试验组的胆固醇、三酰甘油指标低于对照组,高密度脂蛋白高于对照组。试验组的总有效率明显高于对照组的总有效率,具有统计学意义(P<0.05)。结论治疗高血压合并冠心病,使用氨氯地平阿托伐他汀钙片药物,临床效果较好,降脂疗效明显,患者的心功能有所提升,值得在临床上推广。
Objective To investigate the clinical efficacy of amlodipine atorvastatin calcium in the treatment of patients with hypertension and coronary heart disease. Methods Eighty patients with hypertension and coronary heart disease admitted to our hospital were enrolled in this study. They were randomly divided into experimental group (40 cases) and control group (40 cases). The experimental group was treated with oral amlodipine atorvastatin calcium, and the control group was treated with atorvastatin. The total effective rate of the two groups was compared with the cholesterol, triglyceride and high density lipoprotein of the patients after treatment. Results After treatment, the physical condition of all patients improved. The cholesterol and triglyceride of the experimental group were lower than those of the control group, while the high density lipoprotein was higher than the control group. The total effective rate of the experimental group was significantly higher than that of the control group, with statistical significance (P <0.05). Conclusion The treatment of hypertension with coronary heart disease, the use of amlodipine atorvastatin calcium tablets, the clinical effect is better, lipid-lowering effect is obvious, the patient’s cardiac function has improved, worth the promotion in the clinic.